Apoptosis

Apoptosis is a form of programmed cell death in which cells activate intracellular enzymes that methodically dismantle their own nuclear DNA, nuclear envelope, and cytoplasmic proteins. The dying cell fragments into membrane-bound apoptotic bodies that are rapidly phagocytosed by macrophages — the plasma membrane remains intact throughout, so cellular contents never spill out and no inflammatory reaction is triggered. This distinguishes apoptosis sharply from necrosis.

Morphological Features

Feature	Description
Cell shrinkage	Cytoplasm condenses; organelles pack more tightly
Chromatin condensation	Nuclear chromatin aggregates at the nuclear envelope (pyknosis)
Nuclear fragmentation	Nucleus breaks into discrete pieces (karyorrhexis)
Membrane blebbing	Plasma membrane blebs outward
Apoptotic bodies	Cell fragments into membrane-enclosed particles
Phagocytosis	Bodies cleared by macrophages/neighboring cells without inflammation

When Apoptosis Occurs

Physiologic situations (essential, beneficial):

Embryonic development — sculpting organs, eliminating interdigital webbing
Turnover of proliferating tissues (intestinal epithelium, lymphocytes)
Involution of hormone-dependent tissues (endometrium after menstruation)
Eliminating self-reactive lymphocytes to prevent autoimmunity
Culling surplus leukocytes after an immune response resolves

Pathologic situations (damage-triggered):

Severe DNA damage (radiation, cytotoxic drugs) — p53-mediated
Accumulation of misfolded proteins (ER stress)
Certain viral infections
Cytotoxic T lymphocyte (CTL)-mediated killing of infected/tumor cells

The Two Pathways of Apoptosis

Both converge on caspase activation — cysteine proteases that cleave proteins after aspartic acid residues. Initiator caspases (caspase-8, -9) activate executioner caspases (caspase-3, -6, -7), which carry out the actual demolition.

Apoptosis pathways diagram showing extrinsic and intrinsic routes converging on caspase activation

1. Intrinsic (Mitochondrial) Pathway

The dominant pathway in most physiologic and pathologic apoptosis.

Trigger: Loss of survival signals, DNA damage, misfolded protein accumulation, hypoxia, toxins.

Key steps:

Sensor proteins called BH3-only proteins (e.g., BIM, BID, PUMA, NOXA) are activated by cellular stress.
They shift the balance toward pro-apoptotic BAX and BAK, which dimerize and insert into the outer mitochondrial membrane, forming channels.
Simultaneously, survival signals drop → levels of anti-apoptotic BCL-2 and BCL-XL fall.
Cytochrome c (and other proteins like SMAC/DIABLO) leaks from the mitochondrial intermembrane space into the cytosol.
Cytochrome c + APAF-1 + pro-caspase-9 assemble into the apoptosome.
The apoptosome activates caspase-9, which cleaves and activates executioner caspases-3 and -7.

BCL-2 family — the master switch:

Pro-apoptotic	Anti-apoptotic
BAX, BAK (pore-formers)	BCL-2, BCL-XL, MCL-1
BH3-only sensors (BIM, BID, PUMA…)

The ratio of pro- to anti-apoptotic BCL-2 family members determines cell fate. In cancer, BCL-2 overexpression (e.g., follicular lymphoma t(14;18)) tips the balance toward survival.

2. Extrinsic (Death Receptor) Pathway

Trigger: Binding of extracellular "death ligands" to surface death receptors.

Key players:

Receptors: FAS (CD95), TNFR1, TRAIL-R (DR4/5) — all members of the TNF receptor superfamily containing a cytoplasmic "death domain."
Ligands: FasL (on activated T cells), TNF-α, TRAIL.

Key steps:

Ligand binds → receptor trimerizes → death domains recruit adaptor protein FADD.
FADD recruits pro-caspase-8 → the Death-Inducing Signaling Complex (DISC) forms.
Proximity-induced auto-cleavage activates caspase-8.
Caspase-8 directly activates executioner caspases-3 and -7.
In some cells (type II), caspase-8 also cleaves BID → truncated tBID → amplifies via the mitochondrial pathway.

c-FLIP (a catalytically inactive caspase-8 homologue) is a key inhibitor that blocks DISC assembly, serving as an anti-apoptotic brake.

The Execution Phase

Once executioner caspases (3, 6, 7) are active, they cleave:

CAD (caspase-activated DNase) — released from its inhibitor ICAD → cleaves DNA into ~180 bp fragments (ladder pattern on gel electrophoresis)
Nuclear lamins → nuclear envelope breakdown
Cytoskeletal proteins → cell shrinkage and blebbing
Various signaling proteins → cell disassembly

Clearance: "Eat-Me" Signals

Apoptotic cells display phosphatidylserine (PS) on the outer leaflet of the plasma membrane (normally inner leaflet only). This "eat-me" signal is recognized by phagocyte receptors (e.g., TIM-4, MerTK) → efferocytosis (phagocytic clearance) without triggering inflammation.

Apoptosis vs. Necrosis

Feature	Apoptosis	Necrosis
Trigger	Programmed / regulated	Uncontrolled injury
Cell size	Shrinks	Swells
Membrane integrity	Maintained	Disrupted
DNA cleavage	Organized (ladder)	Random
Inflammation	None	Yes (DAMPs released)
Fate of debris	Phagocytosed as bodies	Lysed, contents spill

Clinical Significance

Condition	Apoptosis role
Cancer	BCL-2 overexpression or caspase loss → cells evade apoptosis → uncontrolled proliferation
Neurodegenerative disease	Excess apoptosis of neurons (Alzheimer's, Parkinson's, ALS)
Autoimmunity	Failure to eliminate self-reactive lymphocytes via Fas pathway (e.g., ALPS — autoimmune lymphoproliferative syndrome)
Ischemic injury	Apoptosis at the ischemic penumbra following stroke/MI
HIV	CD4+ T cell depletion partly via apoptosis
Therapeutics	Venetoclax (BCL-2 inhibitor) reactivates apoptosis in CLL; many chemotherapeutics work by triggering the intrinsic pathway

Sources: Robbins & Kumar Basic Pathology, p. 24–26; Sleisenger & Fordtran's Gastrointestinal and Liver Disease, p. 23.

This is a shared conversation. Sign in to Orris to start your own chat.